Invesco Biotechnology & Genome ETF
PBE
PBE
81 hedge funds and large institutions have $59.7M invested in Invesco Biotechnology & Genome ETF in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 27 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
13
Reduced
27
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RF
76
Robbins Farley
Bedford,
New Hampshire
| $6K | +$6K | +88 | New |
|
|
WWM
77
Wagner Wealth Management
Greenville,
South Carolina
| $4K | +$4K | +50 | New |
|
|
BFEC
78
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $3K | -$3.75K | -50 | -56% |
|
|
AIP
79
Ameritas Investment Partners
Lincoln,
Nebraska
| $3K | – | – | – |
|
|
NDSI
80
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
| $894 | -$84 | -1,200 | -9% |
|
81
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$730K | -12,900 | Closed |
|
|
CAM
82
Cresset Asset Management
Chicago,
Illinois
| – | -$226K | -4,000 | Closed |
|
83
HighTower Advisors
Chicago,
Illinois
| – | -$224K | -3,987 | Closed |
|
|
CPW
84
Catalyst Private Wealth
San Mateo,
California
| – | -$96K | -1,700 | Closed |
|